MK-1708 / Merck (MSD) - LARVOL DELTA

A Clinical Study of MK-1708 in Healthy Elderly Participants (MK-1708-005) (clinicaltrials.gov) - P1 | N=16 | Completed | Sponsor: Merck Sharp & Dohme LLC | Active, not recruiting ➔ Completed

Trial completion

A Clinical Study of MK-1708 in Healthy Elderly Participants (MK-1708-005) (clinicaltrials.gov) - P1 | N=16 | Active, not recruiting | Sponsor: Merck Sharp & Dohme LLC | Recruiting ➔ Active, not recruiting

Enrollment closed

MK-1708-008: A Study to Evaluate the Effects of Itraconazole on MK-1708 in Healthy Participants (MK-1708-003) (clinicaltrials.gov) - P1 | N=12 | Completed | Sponsor: Merck Sharp & Dohme LLC | Active, not recruiting ➔ Completed

Trial completion • Alzheimer's Disease • CNS Disorders

MK-1708-008: A Study to Evaluate the Effects of Itraconazole on MK-1708 in Healthy Participants (MK-1708-003) (clinicaltrials.gov) - P1 | N=12 | Active, not recruiting | Sponsor: Merck Sharp & Dohme LLC | Recruiting ➔ Active, not recruiting

Enrollment closed • Alzheimer's Disease • CNS Disorders

A Clinical Study of MK-1708 in Healthy Elderly Participants (MK-1708-005) (clinicaltrials.gov) - P1 | N=16 | Recruiting | Sponsor: Merck Sharp & Dohme LLC | Not yet recruiting ➔ Recruiting

Enrollment open

MK-1708-008: A Study to Evaluate the Effects of Itraconazole on MK-1708 in Healthy Participants (MK-1708-003) (clinicaltrials.gov) - P1 | N=12 | Recruiting | Sponsor: Merck Sharp & Dohme LLC | Not yet recruiting ➔ Recruiting

Enrollment open • Alzheimer's Disease • CNS Disorders

A Clinical Study of MK-1708 in Healthy Elderly Participants (MK-1708-005) (clinicaltrials.gov) - P1 | N=16 | Not yet recruiting | Sponsor: Merck Sharp & Dohme LLC

New P1 trial

A Study to Evaluate the Effects of Itraconazole on MK-1708 in Healthy Participants (MK-1708-008) (clinicaltrials.gov) - P1 | N=12 | Not yet recruiting | Sponsor: Merck Sharp & Dohme LLC

New P1 trial • Alzheimer's Disease • CNS Disorders

Single and Multiple Dose Study of MK-1708 in Healthy Japanese Participants (MK-1708-004) (clinicaltrials.gov) - P1 | N=64 | Not yet recruiting | Sponsor: Merck Sharp & Dohme LLC

New P1 trial • Alzheimer's Disease • Amyotrophic Lateral Sclerosis • CNS Disorders